ERYTECH Provides Business Update And Financial Results For The Full Year 2014
LYON, France--(BUSINESS WIRE)--Regulatory News:
ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: ERYP & OTC US: EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, provides a business update and reports its financial results for the period ending December 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
ERYTECH (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: ERYP & OTC US: EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical needs, provides a business update and reports its financial results for the period ending December 31, 2014.
Help employers find you! Check out all the jobs and post your resume.